IL154275A0 - Tartrate salts of thiazolidinedione derivative - Google Patents

Tartrate salts of thiazolidinedione derivative

Info

Publication number
IL154275A0
IL154275A0 IL15427501A IL15427501A IL154275A0 IL 154275 A0 IL154275 A0 IL 154275A0 IL 15427501 A IL15427501 A IL 15427501A IL 15427501 A IL15427501 A IL 15427501A IL 154275 A0 IL154275 A0 IL 154275A0
Authority
IL
Israel
Prior art keywords
tartrate salts
thiazolidinedione derivative
thiazolidinedione
derivative
tartrate
Prior art date
Application number
IL15427501A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL154275A0 publication Critical patent/IL154275A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
IL15427501A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative IL154275A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
IL154275A0 true IL154275A0 (en) 2003-09-17

Family

ID=9897026

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15427501A IL154275A0 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative
IL154275A IL154275A (en) 2000-08-04 2003-02-03 5 - [4 - [2 - (N - methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 4, 2 - Dion, DL Tartrate, their preparation and use in the preparation of drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154275A IL154275A (en) 2000-08-04 2003-02-03 5 - [4 - [2 - (N - methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 4, 2 - Dion, DL Tartrate, their preparation and use in the preparation of drugs

Country Status (37)

Country Link
US (1) US20040014790A1 (xx)
EP (1) EP1305311B1 (xx)
JP (1) JP2004505970A (xx)
KR (1) KR100755174B1 (xx)
CN (1) CN1455778A (xx)
AP (1) AP1785A (xx)
AT (1) ATE384059T1 (xx)
AU (1) AU2001276506A1 (xx)
BG (1) BG107604A (xx)
BR (1) BR0112982A (xx)
CA (1) CA2417827A1 (xx)
CY (1) CY1107252T1 (xx)
CZ (1) CZ2003313A3 (xx)
DE (1) DE60132461T2 (xx)
DK (1) DK1305311T3 (xx)
DZ (1) DZ3418A1 (xx)
EA (1) EA005408B1 (xx)
EC (1) ECSP034467A (xx)
ES (1) ES2296772T3 (xx)
GB (1) GB0019224D0 (xx)
HK (1) HK1057358A1 (xx)
HR (1) HRP20030068B1 (xx)
HU (1) HUP0300778A3 (xx)
IL (2) IL154275A0 (xx)
MA (1) MA25832A1 (xx)
MX (1) MXPA03001085A (xx)
NO (1) NO324596B1 (xx)
NZ (1) NZ524030A (xx)
OA (1) OA12354A (xx)
PL (1) PL360662A1 (xx)
PT (1) PT1305311E (xx)
SI (1) SI1305311T1 (xx)
SK (1) SK1462003A3 (xx)
UA (1) UA76720C2 (xx)
WO (1) WO2002012232A1 (xx)
YU (1) YU14603A (xx)
ZA (1) ZA200300961B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CN108348292B (zh) 2015-10-27 2021-04-27 纳诺帕斯技术有限公司 具有机械性导引的微针装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR100755174B1 (ko) 2007-09-03
AU2001276506A1 (en) 2002-02-18
JP2004505970A (ja) 2004-02-26
HUP0300778A2 (hu) 2003-11-28
ZA200300961B (en) 2004-04-01
DE60132461T2 (de) 2008-12-24
NZ524030A (en) 2004-07-30
PL360662A1 (en) 2004-09-20
HUP0300778A3 (en) 2005-04-28
SK1462003A3 (en) 2004-06-08
EA005408B1 (ru) 2005-02-24
CY1107252T1 (el) 2012-11-21
WO2002012232A1 (en) 2002-02-14
PT1305311E (pt) 2008-04-07
CN1455778A (zh) 2003-11-12
CA2417827A1 (en) 2002-02-14
AP2003002736A0 (en) 2003-03-31
MA25832A1 (fr) 2003-07-01
YU14603A (sh) 2006-05-25
BR0112982A (pt) 2003-08-26
SI1305311T1 (sl) 2008-04-30
IL154275A (en) 2009-02-11
MXPA03001085A (es) 2003-05-27
EP1305311A1 (en) 2003-05-02
BG107604A (bg) 2003-09-30
US20040014790A1 (en) 2004-01-22
DK1305311T3 (da) 2008-05-19
ATE384059T1 (de) 2008-02-15
DE60132461D1 (de) 2008-03-06
EA200300230A1 (ru) 2003-06-26
AP1785A (en) 2007-10-04
HRP20030068A2 (en) 2005-02-28
KR20030022355A (ko) 2003-03-15
NO20030530D0 (no) 2003-02-03
EP1305311B1 (en) 2008-01-16
UA76720C2 (uk) 2006-09-15
CZ2003313A3 (cs) 2004-02-18
ECSP034467A (es) 2003-03-31
OA12354A (en) 2004-03-19
ES2296772T3 (es) 2008-05-01
NO324596B1 (no) 2007-11-26
DZ3418A1 (fr) 2002-02-14
GB0019224D0 (en) 2000-09-27
NO20030530L (no) 2003-02-03
HK1057358A1 (en) 2004-04-02
HRP20030068B1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
SI1686119T1 (sl) Derivati pirimidin-5-ona kot inhibitorji ldl-pla2
HK1064035A1 (en) Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
HK1057359A1 (en) Tartrate salts of thiazolidinedione derivative
IL154275A0 (en) Tartrate salts of thiazolidinedione derivative
IL154277A0 (en) Tartrate salts of thiazolidinedione derivative
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
HK1057360A1 (en) Tartrate salts of thiazolidinedione derivative
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona
HK1045948A1 (zh) 奧美拉唑的新結晶形式
PL340617A1 (en) Derivatives of 2-acylpyridine
SI1301469T1 (sl) Priprava 4-tioalkilbromobenzenskih derivatov

Legal Events

Date Code Title Description
FF Patent granted